Neuroone Medical Technologies (NMTC) Non-Current Deferred Tax Liability (2021 - 2022)
Neuroone Medical Technologies posted quarterly Non-Current Deferred Tax Liability of $140538.0 for Q3 2022, up 118.94% year-on-year from $64189.0 in Q3 2021, and up 118.94% on a QoQ basis from $64189.0 in Q3 2021.
Neuroone Medical Technologies (NMTC) has 2 years of Non-Current Deferred Tax Liability data on file, last reported at $140538.0 in Q3 2022.
- For the quarter ending Q3 2022, Non-Current Deferred Tax Liability rose 118.94% year-over-year to $140538.0; the trailing twelve-month figure through Sep 2022 stood at $140538.0 (up 118.94% YoY), and the FY2022 full-year result was $140538.0, up 118.94% from the prior year.
- Non-Current Deferred Tax Liability for Q3 2022 stood at $140538.0, up from $64189.0 in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $140538.0 in Q3 2022 and bottomed at $64189.0 in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Neuroone Medical Technologies | 31.39 Mn | 28.59 Mn | 1.29 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 140,538.00 |
| Sep 30, 2022 | 140,538.00 |
| Sep 30, 2021 | 64,189.00 |
| Sep 30, 2021 | 64,189.00 |